0
Prevail Therapeutics Inc. Banner Image

Prevail Therapeutics Inc. has reached its limit for free report views

Work for Prevail Therapeutics Inc.? Upgrade Your Profile and unlock all your annual reports.

Prevail Therapeutics Inc.

  • Ticker PRVL
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Prevail Therapeutics Inc. Logo Image
  • 1-10 Employees
  • Based in New York City, New York
Prevail is a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases. The Company is developing PR001 for patients with Parkinson’s disease with GBA1 mutations (PD-GBA) and neuronopathic Gaucher disease; PR006 for patients with frontotemporal dementiaMore with GRN mutations (FTD-GRN); and PR004 for patients with certain synucleinopathies.
Prevail Therapeutics Inc.

Most Recent Annual Report

Prevail Therapeutics Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Prevail Therapeutics Inc. has reached its limit for free report views.